Numinus, which specializes in psychedelic research, will study MDMA-assisted therapy on 20 people
Gordon McIntyre
Payton Nyquvest, founder and CEO of Numinus.PNG
Article content
A Vancouver psychedelics company has been granted approval from Health Canada…
Feds approve Vancouver psychedelics company’s trial use of ecstasy to treat PTSD – Vancouver Sun
Share this article
More News

Solana brings crypto payments to WSOP for the first time
June 10, 2026

Solana brings crypto payments to WSOP for the first time
June 10, 2026



The Contrarian Case for Buying Crypto in 2026
June 10, 2026
